Maddaloni
Jaime A. Maddaloni, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20130282483 | MULTI-DIMENSIONAL METHOD FOR OPTIMIZED DELIVERY OF TARGETED ON-LINE BRAND ADVERTISEMENTS - A method of delivering targeted on-line advertising to an end user of a computer network system comprises creating an advertisement campaign having a plurality of dimensions associated therewith, obtaining end user data based upon engagement of the end user with the network system, profiling advertisement content available on the network system to identify specific items of advertisement content that are compatible with the advertising campaign, for each item of compatible advertisement content, utilizing the end user data and metrics associated with the plurality of dimensions associated with the advertisement campaign to develop an effectiveness measurement, and utilizing the effectiveness measurements to select at least one item of compatible advertisement content for display to the end user. | 10-24-2013 |
Jamie Maddaloni, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20130132212 | REAL-TIME DYNAMIC PAGE AWARENESS FOR AD SERVING - An ad serving platform utilizes real time dynamic page awareness for ad serving. For every new digital content URL, the ad serving platform reviews the layout and relative position of ad placements in a content environment and stores a “map” of this information, which is accessible to the ad server in real time for use in ad selection, and is refreshed periodically (e.g., every three minutes) to account for changes. As a result, without control of the page, the ad server platform can make complex serving decisions based upon relative page position of advertising placements. | 05-23-2013 |
20130144712 | SYSTEMS AND METHODS FOR GROUP DELIVERY, GROUP COUNTING AND GROUP PACING OF AD DELIVERY ON THE WORLD WIDE WEB - Through the utilization of group delivery, group counting and group pacing, an ad serving platform treats a grouping of ads as a standard unit despite the multiple ad unit components. The ad server platform paces and manages the flight of that grouped set of ads as a single entity. The ad server platform guarantees quality of delivery by only counting a qualified impression event when the group delivery has been successful, thereby opening this type of highly impactful advertising experience up to non-standard inventory sources, rather than relying on highly controlled content environments. | 06-06-2013 |
Massimo Maddaloni, Bozeman, MT US
Patent application number | Description | Published |
---|---|---|
20090169578 | TOLERIZING AGENTS - Described herein is the development of fusion proteins useful for inducing tolerance in a subject. In particular embodiments, the tolerizing agents are useful for influence autoimmune, inflammatory, and/or allergic reactions. Example tolerizing fusion proteins contain a targeting portion (which delivers the fusion protein) and a toleragen or allergen or other antigen to which tolerance is desired in a subject. In particular examples, it is demonstrated that a pσ1 fusion protein, when administered orally, facilitates systemic and mucosal tolerance. Also described is the nasal delivery of fusion proteins, for instance for restoring immunogenicity. | 07-02-2009 |
20110135678 | TOLERIZING AGENTS - Described herein is the development of fusion proteins useful for inducing tolerance in a subject. In particular embodiments, the tolerizing agents are useful for influence autoimmune, inflammatory, and/or allergic reactions. Example tolerizing fusion proteins contain a targeting portion (which delivers the fusion protein) and a toleragen or allergen or other antigen to which tolerance is desired in a subject. In particular examples, it is demonstrated that a pσ1 fusion protein, when administered orally, facilitates systemic and mucosal tolerance. Also described is the nasal delivery of fusion proteins, for instance for restoring immunogenicity. | 06-09-2011 |
20140086950 | RECOMBINANT LACTOCOCCUS LACTIS EXPRESSING ESCHERICHIA COLI COLONIZATION FACTOR ANTIGEN I (CFA/I) FIMBRIAE AND THEIR METHODS OF USE - The present disclosure relates generally to therapeutic compositions comprising recombinant bacteria. Further, the disclosure elaborates upon methods of utilizing the taught therapeutic compositions to treat autoimmune and inflammatory disease. The present teachings also relate to the disclosed recombinant bacteria and methods of producing the recombinant bacteria utilized in the compositions and methods. Further taught herein are dietary supplements and food additive compositions comprising the taught recombinant bacteria. | 03-27-2014 |
Richard Maddaloni, Mechanicville, NY US
Patent application number | Description | Published |
---|---|---|
20100285379 | Transitioning an electrochemical cell stack between a power producing mode and a pumping mode - A technique includes operating an electrochemical cell stack in a power producing mode, including communicating a fuel flow in an anode chamber of the stack and communicating an oxidant flow in a cathode chamber of the stack. The technique includes halting the oxidant flow and monitoring a voltage of the stack while the oxidant flow is halted, and in response to the voltage decreasing below a predefined threshold, transitioning the stack into an electrochemical cell pumping mode. | 11-11-2010 |